On November 11, 2026, the Stochastic Oscillator for POM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 10 instances where the indicator left the oversold zone. In 9 of the 10 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
POM moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for POM crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +7.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where POM advanced for three days, in 57 of 64 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The 10-day RSI Indicator for POM moved out of overbought territory on October 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 4 similar instances where the indicator moved out of overbought territory. In 4 of the 4 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on POM as a result. In 18 of 21 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Moving Average Convergence Divergence Histogram (MACD) for POM turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 6 similar instances when the indicator turned negative. In 6 of the 6 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where POM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
POM broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: POM's P/B Ratio (0.000) is slightly lower than the industry average of (1.378). P/E Ratio (0.000) is within average values for comparable stocks, (-2.174). POM's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (0.947). Dividend Yield (0.000) settles around the average of (0.246) among similar stocks. P/S Ratio (0.043) is also within normal values, averaging (2.504).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. POM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.
Be on the lookout for a price bounce soon.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SCNX's RSI Oscillator exited the oversold zone, 29 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for SCNX just turned positive on October 20, 2026. Looking at past instances where SCNX's MACD turned positive, the stock continued to rise in 34 of 41 cases over the following month. The odds of a continued upward trend are 83%.
Following a +3.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCNX advanced for three days, in 172 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCNX as a result. In 72 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCNX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for SCNX entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. SCNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.012) is normal, around the industry mean (1.378). P/E Ratio (-1.547) is within average values for comparable stocks, (-2.174). SCNX's Projected Growth (PEG Ratio) (0.480) is slightly lower than the industry average of (0.947). Dividend Yield (0.000) settles around the average of (0.246) among similar stocks. SCNX's P/S Ratio (11.779) is slightly higher than the industry average of (2.504).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.
POM | SCNX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 48 | 5 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 28 Undervalued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 35 | 92 | |
P/E GROWTH RATING 1..100 | 100 | 98 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
POM's Valuation (28) in the Electric Utilities industry is significantly better than the same rating for SCNX (97) in the null industry. This means that POM’s stock grew significantly faster than SCNX’s over the last 12 months.
POM's Profit vs Risk Rating (100) in the Electric Utilities industry is in the same range as SCNX (100) in the null industry. This means that POM’s stock grew similarly to SCNX’s over the last 12 months.
SCNX's SMR Rating (98) in the null industry is in the same range as POM (100) in the Electric Utilities industry. This means that SCNX’s stock grew similarly to POM’s over the last 12 months.
POM's Price Growth Rating (35) in the Electric Utilities industry is somewhat better than the same rating for SCNX (92) in the null industry. This means that POM’s stock grew somewhat faster than SCNX’s over the last 12 months.
SCNX's P/E Growth Rating (98) in the null industry is in the same range as POM (100) in the Electric Utilities industry. This means that SCNX’s stock grew similarly to POM’s over the last 12 months.
| POM | SCNX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 78% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 2 days ago 89% | 4 days ago 82% |
| Declines ODDS (%) | 18 days ago 90% | 8 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 86% | N/A |
| Aroon ODDS (%) | N/A | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
POM’s FA Score shows that 1 FA rating(s) are green while SCNX’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
POM’s TA Score shows that 4 TA indicator(s) are bullish while SCNX’s TA Score has 4 bullish TA indicator(s).
POM (@Drugstore Chains) experienced а +7.10% price change this week, while SCNX (@Drugstore Chains) price change was -11.11% for the same time period.
The average weekly price growth across all stocks in the @Drugstore Chains industry was +7.72%. For the same industry, the average monthly price growth was +25.20%, and the average quarterly price growth was -31.84%.
SCNX is expected to report earnings on Apr 05, 2027.
The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
A.I.dvisor indicates that over the last year, SCNX has been loosely correlated with HKPD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SCNX jumps, then HKPD could also see price increases.
| Ticker / NAME | Correlation To SCNX | 1D Price Change % | ||
|---|---|---|---|---|
| SCNX | 100% | N/A | ||
| HKPD - SCNX | 39% Loosely correlated | +1.91% | ||
| LFMD - SCNX | 22% Poorly correlated | +2.30% | ||
| HITI - SCNX | 20% Poorly correlated | -2.32% | ||
| POM - SCNX | 7% Poorly correlated | +3.75% | ||
| RDGT - SCNX | 6% Poorly correlated | +4.50% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AEF | 8.15 | 0.30 | +3.82% |
| abrdn Emerging Markets ex-China Fund Inc. | |||
| HELX | 43.76 | 1.57 | +3.72% |
| Franklin Genomic Advancements ETF (HELX) | |||
| BKCG | 39.09 | 0.33 | +0.85% |
| BNY Mellon Concentrated Growth ETF (BKCG) | |||
| MLPA | 52.14 | 0.37 | +0.71% |
| Global X MLP ETF (MLPA) | |||
| QCLR | 28.36 | N/A | N/A |
| Global X NASDAQ 100 Collar 95-110 ETF (QCLR) | |||